2015-2017 I earned my first master’s degree in Pharmaceutical Economics & Policy at MCPHS University (Massachusetts College of Pharmacy and Health Science University) where I studied meta-analysis, cost-effectiveness analysis, and biostatistics and later joined Tufts Medical Center CEVR group as a cost-effectiveness data reviewer.
2020-2021 I completed my second master’s degree in Computer Science at Fitchburg State University and had an internship at UTHealth Science at San Antonio for ChIP-seq data analysis on the ROSMAP dataset.
2010-2014 I completed my bachelor’s degree in Applied Psychology at Hunan Normal University.
2021 Fall, I joined Dr. Fabio Morgante’s Lab at Clemson Center for Human Genetics
I am interested in studying psychiatric disorders and its underlying genome-wide association using modern quantitative methods. Given the enormous global burden of neuropsychiatric diseases and mental health disorders, more innovative research studies should be carried out to shed light on understanding the individual and population-level risk factors and improving the accuracy of phenotypic prediction.
Shi C, Lamba N, Zheng LJ, Cote D, Regestein QR, Liu CM, Tran Q, Routh S, Smith TR, Mekary RA, Broekman MLD. Depression and survival of glioma patients: A systematic review and meta-analysis. Clin Neurol Neurosurg. 2018 Sep;172:8-19. doi: 10.1016/j.clineuro.2018.06.016. Epub 2018 Jun 18. PMID: 29957299.